Goldstein Joseph L

Avg. Two Year Performance

No purchase track record
(44%) Avg. Sale Return
(20%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)(3%)(9%)(17%)(44%)
Sale Success Rate22 of 5125 of 5115 of 5117 of 5112 of 51
Drugs » Biotechnology

Director:

Holdings: 6.38K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--